The correct name for Alfuzosin is Alfuzosin Hydrochloride. Alfuzosin Hydrochloride selectively inhibits smooth muscle contractions of the bladder, prostate and urethra, and is used to improve symptoms associated with benign prostatic hyperplasia, such as frequent urination, difficulty urinating, and increased frequency of nocturia. Adverse reactions such as nausea, dry mouth, vomiting, headache, rash, hot flashes (a bout of fever), dizziness, diarrhea, fainting, rapid heartbeat, dyspepsia, postural hypotension, etc., may be experienced after administration of the drug. The drug should be discontinued before anesthesia in patients requiring anesthesia and in patients with coronary artery disease during episodes and worsening of angina. Dizziness may occur when taking this drug, so caution should be exercised by those who operate machines and drive vehicles. It is contraindicated in the following cases: severe hepatic insufficiency; low blood pressure or postural hypotension; hypersensitivity to the drug; children and female patients. If you need to use the drug, please follow the doctor’s instructions strictly, do not use the drug on your own.